This week, it was announced that the drug remdesivir, an antiviral medication developed by Gilead Sciences, had proven effective against COVID-19 in a major study. The drug was found to cut the time of patient recovery by an average of 4 days. Dr. Anthony Fauci has said that remdesivir will set a new “standard of care” for treatment of COVID-19. To learn more about the drug and the results of the study, Christina speaks with Dr. Terese Hammond, pulmonary critical care specialist and one of the principal investigators for the remdesivir trials.
Related show links:
Bobby Gonzalez on social media: Instagram
Christina Pascucci on social media: Instagram | Twitter
KTLA Podcasts on social media: Instagram |Twitter
More podcasts from KTLA: Frank Buckley Interviews | Spoken Dreams | The News Director’s Office | California Cooking | Rich On Tech | Diva Defined with Sheryl Lee Ralph | Home Made with Kirk Hawkins | Mama Mentality with Megan Telles | Keepin’ It Friel: Conversations on Recovery